Science & Innovation
Science & Innovation
Search
Accessibility Statement
Accessability Statement
Benefits & Rewards
We invest in our people so they will stay and grow with us. We offer benefits such as rewards and development opportunities to help retain employees.
Legal Notices
Legal Notices
Twenty years of controlling Lawsonia intracellularis
Twenty years of controlling Lawsonia intracellularis
Prevention is the first line of defense
Prevention is the first line of defense
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches
Monophasic Salmonella Calls for a Comprehensive Vaccination Strategy
Monophasic Salmonella Calls for a Comprehensive Vaccination Strategy
What Our Partners Say
What Our Partners Say
Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, now available in Canada
Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, now available in Canada
Diabetes
Diabetes
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Harold-and-Dorothy-Patient-Discussion-Guide-Factsheet
Andreas Lenk
Andreas Lenk, Head of Legal and Compliance Germany, discusses his role supporting human pharma and animal health business in legal and compliance matters.
Search and apply
Search and apply
Learning and development
We help people grow professionally by maximizing our talent and giving them room to evolve within the company.
Ethics and Compliance
Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner.
COVID-19
COVID-19
Health Canada issues Notice of Compliance (NOC) for Jardiance® (empagliflozin) for the treatment of heart failure with reduced ejection fraction
Health Canada issues Notice of Compliance (NOC) for Jardiance® (empagliflozin) for the treatment of heart failure with reduced ejection fraction
Meet our Team
Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team
Animal Health Partnering
Description Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team
Lung Diseases
Lung Diseases